Categories
| Category | |
|---|---|
| Health Conditions and Concerns | 36% |
| Pharmacy | 27% |
| Health | 27% |
| Others | 10% |
Explore sites in same category:
- ogorimii-med.net Rank 1.4M. Estimated value 1,512$
- ocrahope.org Rank 781.7K. Estimated value 2,760$
- myvision.org Rank 439.1K. Estimated value 4,932$
- gluten.org Rank 887.9K. Estimated value 2,424$
- veri.co Rank 646.5K. Estimated value 3,336$
- kesimpta.com Rank 1.3M. Estimated value 1,668$
- dr-hips.com Rank 1M. Estimated value 2,232$
- ito-jibika.net Rank 1.1M. Estimated value 1,968$
- presspogo.com Rank 663.9K. Estimated value 3,252$
- myeczemateam.com Rank 1.5M. Estimated value 1,392$
Keyword Suggestion
Domain Informations
Ingrezza.com lookup results from whois.rrpproxy.net server:
- Domain created: 2015-12-14T19:54:53Z
- Domain updated: 2023-11-13T03:03:24Z
- Domain expires: 2024-12-14T19:54:53Z 0 Years, 232 Days left
- Website age: 8 Years, 133 Days
- Registrar Domain ID: 1987356034_DOMAIN_COM-VRSN
- Registrar Url: http://www.key-systems.net
- Registrar WHOIS Server: whois.rrpproxy.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +49.68949396850
- Name server:
- NS1-03.AZURE-DNS.COM
- NS2-03.AZURE-DNS.NET
- NS3-03.AZURE-DNS.ORG
- NS4-03.AZURE-DNS.INFO
Network
- inetnum : 52.224.0.0 - 52.255.255.255
- name : MSFT
- handle : NET-52-224-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2024-03-18
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
Technical support
- handle : SINGH683-ARIN
- name : Singh, Prachi
- phone : +1-425-707-5601
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 52.240.155.58
- Location: Chicago United States
- Latitude: 41.8483
- Longitude: -87.6517
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 52.240.155.58)
Spam Check (IP: 52.240.155.58)
Websites Listing
We found Websites Listing below when search with ingrezza.com on Search Engine
INGREZZA® (valbenazine) capsules - tardive dyskinesia …
The most common side effect of INGREZZA is sleepiness (somnolence). Other side effects include changes in balance (balance problems, dizziness) or an increased risk of falls, headache, feelings of restlessness, dry mouth, …
Ingrezza.comFind a specialist | INGREZZA® (valbenazine) capsules
Your email address will be used only for the purpose of sending the PDF and will not be stored. Your Doctor Discussion Guide has been sent. Send to another email. Indication and Important Safety Information. Do not take INGREZZA if you are allergic to valbenazine, or any of the ingredients in INGREZZA. Expand. Collapse. Important Information Approved Use. …
Ingrezza.comFrequently Asked Questions | INGREZZA® (valbenazine) …
4. Does INGREZZA improve uncontrollable body movements? In a clinical study, 7 out of 10 people taking INGREZZA 80 mg saw improvements in tardive dyskinesia (TD) movements at 6 weeks—and many started to see results in as little as 2 weeks. For some people, results may take a little more time. Patients had at least a 1-point reduction on an ...
Ingrezza.comThank you | INGREZZA® (valbenazine) capsules
Please enter a valid email address. Send. Your email address will be used only for the purpose of sending the PDF and will not be stored. Your Doctor Discussion Guide has been sent. Send to another email. Ready to start a conversation about TD treatment? Find a specialist. Whether your uncontrollable body movements are mild, moderate, or severe, connecting with a psychiatry or …
Ingrezza.comContact a Rep | INGREZZA® (valbenazine) capsules | For ...
EMAIL ADDRESS* PRACTICE PHONE NUMBER* PRACTICE ZIP CODE* NPI ID. I would like information about (please choose at least one* and check all that apply): Scheduling an office visit with an INGREZZA representative Clinical results for INGREZZA INBRACE ® Support Program INGREZZA patient resources and Patient Starter Kits Requesting INGREZZA samples Other …
Ingrezzahcp.comINSTRUCTIONS: Please complete and fax this page to 844-394 ...
I certify that the information provided in this INGREZZA ... Office Contact Email: Office Contact Name: Prescriber NPI #: (Original signature required - *If required by applicable law, please attach copies of all prescriptions on official state prescription forms) City: State: ZIP: 2 PRESCRIBER INFORMATION 3 DIAGNOSIS CODE 4 INGREZZA START PROGRAM Tardive Dyskinesia …
Inbracesupportprogram.comIngrezza Treatment Form - INBRACE Support Program
I certify that the information provided in this INGREZZA ... Email: Prescriber NPI #: Provider Phone: City: State: ZIP: Date: Yes. No. Male. Female. DOB: / / Initial. Rx with 80 mg Maintenance Rx . 40 mg once daily x 7 then . 80 mg once daily x 23. 1-month supply. No refills. 80 mg once daily. 1-month supply. Refills # Initial Rx with 40 mg . Maintenance Rx. 40 mg once daily . 1 …
Inbracesupportprogram.comDosing | INGREZZA® (valbenazine) capsules | For Professionals
Start on INGREZZA 40 mg. Continue on INGREZZA. 40 mg, 60 mg, or 80 mg. Initial dosage of INGREZZA ® (valbenazine) capsules is 40 mg once daily for one week1. After the first week, 80 mg is recommended once daily, but 40 mg or 60 mg once daily may be considered based on individual treatment needs, response, and tolerability 1.
Ingrezzahcp.comIngrezza (valbenazine) dose, indications, adverse effects ...
A dose of 40 mg or 60 mg PO once daily may be considered based on clinical response and tolerability. Max: 80 mg/day. ADJUSTMENTS: Valbenazine may cause an increase in the QTc interval in patients who are CYP2D6 poor metabolizers (CYP2D6 PMs); therefore, the recommended dose in CYP2D6 PMs is 40 mg/day.
Pdr.netIngrezza (Valbenazine) Prior Authorization Request Form
Prescriber specialty: email address: npi number: dea number: phone number: fax number: street address: city: state: zip code: requestor (if different than prescriber): office contact person: medication or medical dispensing information medication name: dose/strength: frequency: length of therapy/refills:
Benefits.cat.comNeurocrine Biosciences: New Treatment Launch Email Template
Launch email template to engage healthcare providers for new treatment. A Great Idea provided design and front-end development for email communications including HTML5 and CSS.
Weareagi.comAustedo vs Ingrezza: How do they compare?
2021-09-23 · Ingrezza 80mg dose had statistically significant improvement in tardive dyskinesia symptoms in 6 weeks. Austedo 36 mg had statistically significant improvement in tardive dyskinesia symptoms in 12 weeks. In the Ingrezza 40mg trial and the Austedo 24mg trial there was an improvement in scores but they were not clinically significant.
Drugs.comIngrezza oral Interactions with Other Medication - WebMD
Does INGREZZA Interact with other Medications? Severe Interactions . These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or …
Webmd.comDailyMed - INGREZZA- valbenazine capsule INGREZZA ...
2021-04-23 · The molecular formula of valbenazine free base is C 24 H 38 N 2 O 4 and its molecular weight is 418.57. INGREZZA capsules are intended for oral administration only. Each capsule contains 73 mg, 109 mg or 146 mg of valbenazine tosylate equivalent to 40 mg, 60 mg or 80 mg of valbenazine free base, respectively.
Dailymed.nlm.nih.govIngrezza oral: Uses, Side Effects, Interactions, Pictures ...
Ingrezza - Uses, Side Effects, and More Generic Name: valbenazine Valbenazine is used to treat involuntary movements of the face, tongue , or other body parts ( tardive dyskinesia ).
Webmd.comIngrezza (Valbenazine) Oral: Uses, Side Effects, Dosages
2021-11-11 · Ingrezza (valbenazine) is an oral prescription medication used to treat and prevent tardive dyskinesia, a movement disorder that develops as a side effect of certain medications. It is available in capsule form. Ingrezza is a vesicular monoamine transporter 2 (VMAT2) inhibitor that reduces the release of extra amounts of certain ...
Verywellhealth.comCommon and Rare Side Effects for Ingrezza oral - WebMD
Joint pain. dizziness. abnormal manner of walking. loss of muscle coordination. headache. nausea. vomiting. nervousness. a change in the ability to pay attention.
Webmd.comIngrezza label gives Neurocrine a competitive edge - Evaluate
2017-04-12 · Both Ingrezza and Austedo are altered versions of tetrabenazine, which is now available generically but was hampered by a strict REMS program. While the cost at which Neurocrine will launch remains unknown it previously guided to an annual price of $20,000-$60,000 for its 40mg dose. Teva has implied that its tardive dyskinesia dose of 24mg will cost …
Evaluate.comNeurocrine Biosciences Provides Preliminary Fourth Quarter ...
2020-01-12 · Preliminary Fourth Quarter and Full-Year 2019 INGREZZA ® (valbenazine) Net Product Sales and Financial Results (Unaudited). Based on preliminary unaudited financial information, the Company expects INGREZZA net product sales for the three months and full-year ended December 31, 2019 to be approximately $238 million and $753 million, …
Neurocrine.gcs-web.comIngrezza Initiation Pack oral: Uses, Side Effects ...
Ingrezza Initiation Pack 40 Mg (7)-80 (21) Capsules In A Dose Dopamine-Depleting Agents - Uses, Side Effects, and More Generic Name: valbenazine . …
Webmd.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| ateliware.com | goaustraliadomains.com | -1 Years, -248 Days |
| rambol.com | markmonitor.com | -1 Years, -74 Days |
| cookedandloved.com | tucows.com | -1 Years, -273 Days |
| linktofish.org | namecheap.com | -2 Years, -4 Days |
| cqlcorp.com | godaddy.com | 4 Years, 202 Days |
| cchuila.org | whois.godaddy.com | -1 Years, -200 Days |
| nettruyentwo.com | namecheap.com | -2 Years, -27 Days |
| dollarzoneonline.com | godaddy.com | -2 Years, -24 Days |
| sankhyiki.in | godaddy.com | 2 Years, 258 Days |
| vpn-mentors.com | godaddy.com | -1 Years, -264 Days |